Xenon Pharmaceuticals (XENE) Tops Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Join SI Premium – FREE
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.83), $0.08 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $7.5 million versus the consensus estimate of $1.25 million.
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- X Financial (XYF) Tops Q2 EPS by 438c
- Mackay Gold & Silver acquires Comstock Nevada mining assets
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
